EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPY IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS TYPE I, II, AND VI: A SINGLE-CENTER COHORT STUDY

Background. There are limited data on the efficacy of long-term enzyme replacement therapy (ERT) in children with mucopolysaccharidosis (MPS).Objective. Our aim was to study the efficacy and safety of long-term ERT in children with MPS type I, II, and VI.Methods. We analyzed the results of ERT with...

詳細記述

書誌詳細

出版年:	Вопросы современной педиатрии
主要な著者:	Liliia A. Osipova, Ludmila M. Kuzenkova, Leyla S. Namazova-Baranova, Anait K. Gevorkyan, Tatiana V. Podkletnova, Nikolay A. Mayanskiy, Grigoriy V. Revunenkov, Nato D. Vashakmadze
フォーマット:	論文
言語:	英語
出版事項:	"Paediatrician" Publishers LLC 2018-04-01
主題:	children mucopolysaccharidosis enzyme replacement therapy laronidase idursulfase galsulfase glycosaminoglycans
オンライン･アクセス:	https://vsp.spr-journal.ru/jour/article/view/1868